SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc.
MNTA 52.480.0%Oct 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tuck11/10/2015 1:44:00 PM
  Read Replies (2) of 3027
 
"Mixed ruling" from CAFC on Lovenox litigation.

CAFC mEnox ruling

As I understand it: the CAFC vacates the summary judgement wrt to safe harbor. It finds no infringement of the contested patent, siding with Amphastar regarding tested versus made definitions. The District court had denied Momenta the right to mend the litigation wrt infringement of other patents, but did so on the basis of safe harbor, which the CAFC is vacation. I therefore remands to the District court wrt to litigation of other patents.

I invite the more highly trained legal minds to correct me here, if I'm off. Not sure what happens to the bond. Thinking Amphastar collects due to non-infringement, but no stock is moving on this, so maybe not.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext